Does Rallies track congressional trades in OHI?

Yes. Rallies tracks politician and congressional stock disclosures for OHI, including reported purchases, sales, dates, owners, and trade amounts when available.

Is OHI research on Rallies investment advice?

No. Rallies provides research, data, and educational context for OHI. It does not provide personalized investment advice.

OHI (Omega Healthcare Investors Inc.) Stock Analysis - Politician Trades

Omega Healthcare Investors Inc. (OHI) is a publicly traded Real Estate sector company. As of May 21, 2026, OHI trades at $48.75 with a market cap of $14.39B and a P/E ratio of 23.54. OHI moved +0.53% today. Year to date, OHI is +12.00%; over the trailing twelve months it is +30.57%. Its 52-week range spans $35.04 to $49.33. Analyst consensus is buy with an average price target of $50.22. Rallies surfaces OHI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Which politicians traded OHI stock?

Recent politician trading activity in OHI includes disclosures from Thomas R. Carper and Thomas R. Carper. Rallies tracks purchase and sale disclosures, transaction dates, owners, reported amounts, and post-trade performance context.

OHI Key Metrics

Key financial metrics for OHI
Metric	Value
Price	$48.75
Market Cap	$14.39B
P/E Ratio	23.54
EPS	$2.08
Dividend Yield	0.67%
52-Week High	$49.33
52-Week Low	$35.04
Volume	1.03K
Avg Volume	0
Revenue (TTM)	$1.24B
Net Income	$655.98M
Gross Margin	0.00%

Congressional Trades in OHI

Thomas R. Carper sale (full) OHI on Nov 20, 2020 (amount: $15.00K) for Spouse.
Thomas R. Carper sale (full) OHI on Jul 9, 2020 (amount: $15.00K) for Spouse.

Latest OHI News

Omega Healthcare Investors jumps as traders position ahead of April 28 earnings — Apr 23, 2026
Omega Healthcare Investors Secures Buy Rating; Stakes Raised by 5.6% and 3.4% — Apr 14, 2026
Omega Healthcare Investors Trades at 14.6x P/E, 1.47 PEG and 2.58 P/B with D Value Grade — Mar 4, 2026
Omega Healthcare Sees 2.5% Q4 NOI Growth, 83.1% Occupancy and $100M Financing — Feb 7, 2026
Omega Healthcare’s Q4 Net Income Climbs 48%, Completes $334M Investments — Feb 5, 2026

Recent OHI Insider Trades

Gupta Vikas bought 11.50K (~$494.12K) on Nov 6, 2025.
PICKETT C TAYLOR bought 20.00K (~$862.86K) on Nov 5, 2025.
Egbuonu-Davis Lisa sold 200 (~$8.03K) on Aug 8, 2025.

OHI Analyst Consensus

10 analysts cover OHI: 0 strong buy, 4 buy, 5 hold, 1 sell, 0 strong sell. Consensus rating is buy. Average price target: $50.22.

Common questions about OHI

Which politicians traded OHI stock?: Recent politician trading activity in OHI includes disclosures from Thomas R. Carper and Thomas R. Carper. Rallies tracks purchase and sale disclosures, transaction dates, owners, reported amounts, and post-trade performance context.
Does Rallies track congressional trades in OHI?: Yes. Rallies tracks politician and congressional stock disclosures for OHI, including reported purchases, sales, dates, owners, and trade amounts when available.
Is OHI research on Rallies investment advice?: No. Rallies provides research, data, and educational context for OHI. It does not provide personalized investment advice.